PubMed

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): A Retrospective Analysis.

McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamensky G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J; for the CORONA Study Group.

Circulation. 2009 Dec 1;120(22):2188-2196. Epub 2009 Nov 16.PMID: 19917888 [PubMed - as supplied by publisher]Related articles

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9.PMID: 19892235 [PubMed - in process]Related articles

Is there a heart rate paradox--demystification of the myths?

Kjekshus J.

J Intern Med. 2009 Sep;266(3):242-7. No abstract available. PMID: 19702792 [PubMed - indexed for MEDLINE]Related articles

Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study.

Wethal T, Lund MB, Edvardsen T, Fosså SD, Pripp AH, Holte H, Kjekshus J, Fosså A.

Br J Cancer. 2009 Aug 18;101(4):575-81. Epub 2009 Jul 21.PMID: 19623176 [PubMed - indexed for MEDLINE]Related articles

Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure.

Kjekshus JK, Torp-Pedersen C, Gullestad L, Køber L, Edvardsen T, Olsen IC, Sjaastad I, Qvigstad E, Skomedal T, Osnes JB, Levy FO.

Eur J Heart Fail. 2009 Aug;11(8):771-8. Epub 2009 Jun 30.PMID: 19567409 [PubMed - in process]Related articles

The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).

Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H; MERIT-HF Study Group.

J Card Fail. 2009 May;15(4):310-8. Epub 2008 Dec 23.PMID: 19398079 [PubMed - in process]Related articles

Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial.

Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, Kjekshus J, Ponikowski P, Dickstein K; OPTIMAAL Investigators.

Eur Heart J. 2009 Jun;30(11):1331-9. Epub 2009 Apr 21.PMID: 19383732 [PubMed - indexed for MEDLINE]Related articles

A helicopter flight does not induce significant changes in systemic biomarker profiles.

Kåsin JI, Kjekshus J, Aukrust P, Mollnes TE, Wagstaff A.

Scand J Clin Lab Invest. 2009;69(4):462-74.PMID: 19333819 [PubMed - indexed for MEDLINE]Related articles

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure.

Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P.

Eur Heart J. 2009 May;30(10):1229-36. Epub 2009 Mar 26.PMID: 19329498 [PubMed - in process]Related articles

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.

Wedel H, McMurray JJ, Lindberg M, Wikstrand J, Cleland JG, Cornel JH, Dunselman P, Hjalmarson A, Kjekshus J, Komajda M, Kuusi T, Vanhaecke J, Waagstein F; CORONA Study Group.

Eur J Heart Fail. 2009 Mar;11(3):281-91. Epub 2009 Jan 24.PMID: 19168876 [PubMed - indexed for MEDLINE]Related articles

Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S).

Huskey J, Lindenfeld J, Cook T, Targher G, Kendrick J, Kjekshus J, Pedersen T, Chonchol M.

Atherosclerosis. 2009 Jul;205(1):202-6. Epub 2008 Nov 18.PMID: 19124121 [PubMed - indexed for MEDLINE]Related articles

The perfect biomarker in acute coronary syndrome: a challenge for diagnosis, prognosis, and treatment.

Gravning J, Kjekshus J.

Eur Heart J. 2008 Dec;29(23):2827-8. Epub 2008 Oct 28. No abstract available. PMID: 18957473 [PubMed - indexed for MEDLINE]Related articles

Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.

Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD.

J Cancer Surviv. 2007 Mar;1(1):8-16.PMID: 18648940 [PubMed - indexed for MEDLINE]Related articles

Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.

Gravning J, Ueland T, Mørkrid L, Endresen K, Aaberge L, Kjekshus J.

Scand Cardiovasc J. 2008 Jun;42(3):214-21.PMID: 18569954 [PubMed - indexed for MEDLINE]Related articles

What are the effects of patient age and blood pressure on the cholesterol-related risk of vascular mortality?

Kjekshus J.

Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):310-1. Epub 2008 Apr 29. No abstract available. PMID: 18446135 [PubMed]Related articles

Risk associated with statin treatment.

Kjekshus J.

J Am Coll Cardiol. 2008 Jan 1;51(1):91; author reply 92. No abstract available. PMID: 18174047 [PubMed - indexed for MEDLINE]Related articles

Rosuvastatin in older patients with systolic heart failure.

Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Group.

N Engl J Med. 2007 Nov 29;357(22):2248-61. Epub 2007 Nov 5.PMID: 17984166 [PubMed - indexed for MEDLINE]Related articlesFree article

Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival.

Kjekshus J.

Eur J Heart Fail. 2007 Sep;9(9):962; author reply 962-3. Epub 2007 Jul 24. No abstract available. PMID: 17652021 [PubMed - indexed for MEDLINE]Related articles

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.

Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J.

Am J Kidney Dis. 2007 Mar;49(3):373-82.PMID: 17336698 [PubMed - indexed for MEDLINE]Related articles

Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization.

Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):614-20. Epub 2006 Dec 14.PMID: 17170367 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction.

Estensen ME, Hognestad A, Syversen U, Squire I, Ng L, Kjekshus J, Dickstein K, Omland T.

Am Heart J. 2006 Nov;152(5):927.e1-6.PMID: 17070161 [PubMed - indexed for MEDLINE]Related articles

Impact of neurohormonal blockade on association between body mass index and mortality.

Kennedy LM, Anker SD, Kjekshus J, Cook TJ, Willenheimer R.

Int J Cardiol. 2007 Jun 25;119(1):33-40. Epub 2006 Oct 17.PMID: 17052777 [PubMed - indexed for MEDLINE]Related articles

Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction.

Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P.

J Card Fail. 2006 Oct;12(8):659-63.PMID: 17045187 [PubMed - indexed for MEDLINE]Related articles

[Unexpected sudden death after percutaneous coronary intervention]

Gravning J, Vege A, Kjekshus J.

Tidsskr Nor Laegeforen. 2006 Aug 24;126(16):2111-3. Norwegian. PMID: 16960998 [PubMed - indexed for MEDLINE]Related articles

Mechanisms behind the postprandial increase in cardiac output: a clue obtained from transplanted hearts.

Waaler BA, Hisdal J, Ihlen H, Kjekshus J.

Eur J Appl Physiol. 2006 Jul;97(5):516-20. Epub 2006 May 23.PMID: 16718506 [PubMed - indexed for MEDLINE]Related articles

Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study.

van Veldhuisen DJ, Aass H, El Allaf D, Dunselman PH, Gullestad L, Halinen M, Kjekshus J, Ohlsson L, Wedel H, Wikstrand J; MERIT-HF Study Group.

Eur J Heart Fail. 2006 Aug;8(5):539-46. Epub 2006 Mar 29.PMID: 16567126 [PubMed - indexed for MEDLINE]Related articles

A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease.

Holm T, Ueland T, Halvorsen B, Hognestad A, Holm AG, Wergeland R, Gullestad L, Aukrust P, Kjekshus J.

J Am Coll Cardiol. 2006 Mar 7;47(5):1085-6. Epub 2006 Feb 9. No abstract available. PMID: 16516099 [PubMed - indexed for MEDLINE]Related articles

Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.

Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, Gullestad L, Dickstein K, Aukrust P.

J Am Coll Cardiol. 2005 Dec 6;46(11):2018-21. Epub 2005 Nov 9.PMID: 16325035 [PubMed - indexed for MEDLINE]Related articles

Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study.

Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P.

Circulation. 2005 Nov 29;112(22):3408-14. Epub 2005 Nov 21.PMID: 16301340 [PubMed - indexed for MEDLINE]Related articlesFree article

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.

Kjekshus J, Dunselman P, Blideskog M, Eskilson C, Hjalmarson A, McMurray JV, Waagstein F, Wedel H, Wessman P, Wikstrand J; CORONA Study Group.

Eur J Heart Fail. 2005 Oct;7(6):1059-69.PMID: 16227145 [PubMed - indexed for MEDLINE]Related articles

Serial measurements of peripheral vascular reactivity and exercise capacity in congestive heart failure and after heart transplantation.

Hognestad A, Holm T, Simonsen S, Kjekshus J, Andreassen AK.

J Card Fail. 2005 Aug;11(6):447-54.PMID: 16105636 [PubMed - indexed for MEDLINE]Related articles

Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis.

Hognestad A, Endresen K, Wergeland R, Mellembakken JR, Mollnes TE, Omland T, Kjekshus JK, Aukrust P, Andreassen AK.

J Heart Lung Transplant. 2005 Aug;24(8):1026-32.PMID: 16102437 [PubMed - indexed for MEDLINE]Related articles

The impact of morbid events on survival following hospitalization for complicated myocardial infarction.

Dickstein K, Gleim GW, Snapinn S, James MK, Kjekshus J; OPTIMAAL Study Group.

Eur J Heart Fail. 2006 Jan;8(1):74-80. Epub 2005 Aug 2.PMID: 16081319 [PubMed - indexed for MEDLINE]Related articles

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.

Orn S, Cleland JG, Romo M, Kjekshus J, Dickstein K.

Am J Med. 2005 Jul;118(7):752-8.PMID: 15989909 [PubMed - indexed for MEDLINE]Related articles

Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.

Gurantz D, Yndestad A, Halvorsen B, Lunde OV, Omens JH, Ueland T, Aukrust P, Moore CD, Kjekshus J, Greenberg BH.

Cardiovasc Res. 2005 Jul 1;67(1):106-15. Epub 2005 Mar 23.PMID: 15949474 [PubMed - indexed for MEDLINE]Related articlesFree article

Agents targeting inflammation in heart failure.

Gullestad L, Kjekshus J, Damås JK, Ueland T, Yndestad A, Aukrust P.

Expert Opin Investig Drugs. 2005 May;14(5):557-66. Review.PMID: 15926863 [PubMed - indexed for MEDLINE]Related articles

Heart failure and statins--why do we need a clinical trial?

Böhm M, Hjalmarson A, Kjekshus J, Laufs U, McMurray J, van Veldhuisen DJ.

Z Kardiol. 2005 Apr;94(4):223-30.PMID: 15803258 [PubMed - indexed for MEDLINE]Related articles

Soluble CD40 ligand in acute and chronic heart failure.

Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K, Kjekshus J, Gullestad L, Damås JK.

Eur Heart J. 2005 Jun;26(11):1101-7. Epub 2005 Feb 16.PMID: 15716285 [PubMed - indexed for MEDLINE]Related articlesFree article

[Expert Consensus document on beta-adrenergic receptor blockers]

López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Grupo de Trabajo sobre Bloqueadores Beta de la Sociedad Europea de Cardiología.

Rev Esp Cardiol. 2005 Jan;58(1):65-90. Review. Spanish. No abstract available. PMID: 15680133 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J; MERIT-HF Study Group.

Am Heart J. 2005 Jan;149(1):159-67.PMID: 15660048 [PubMed - indexed for MEDLINE]Related articles

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J; MERIT-HF Study Group.

J Am Coll Cardiol. 2005 Jan 18;45(2):252-9.PMID: 15653024 [PubMed - indexed for MEDLINE]Related articles

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C, Priori SG, Alonso García MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernández Burgos E, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Ardissino D, Avendano C, Blomström-Lundqvist C, Clément D, Drexler H, Ferrari R, Fox KA, Julian D, Kearney P, Klein W, Köber L, Mancia G, Nieminen M, Ruzillo W, Simoons M, Thygesen K, Tognoni G, Tritto I, Wallentin L; Task Force on ACE-inhibitors of the European Society of Cardiology; Comité de la ESC para la elaboracion de las Guías de Práctica Clínica.

Rev Esp Cardiol. 2004 Dec;57(12):1213-32. Review. Spanish. No abstract available. PMID: 15617645 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.

Ueland T, Jemtland R, Godang K, Kjekshus J, Hognestad A, Omland T, Squire IB, Gullestad L, Bollerslev J, Dickstein K, Aukrust P.

J Am Coll Cardiol. 2004 Nov 16;44(10):1970-6.PMID: 15542278 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.

Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ; Scandinavian Simavastatin Survival Study Group.

Atheroscler Suppl. 2004 Oct;5(3):99-106. No abstract available. PMID: 15531282 [PubMed - indexed for MEDLINE]Related articles

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Pyörälä K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H; Scandinavian Simvastatin Survival Study Group.

Atheroscler Suppl. 2004 Oct;5(3):81-7. No abstract available. PMID: 15531279 [PubMed - indexed for MEDLINE]Related articles

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

Strandberg TE, Pyörälä K, Cook TJ, Wilhelmsen L, Faergeman O, Thorgeirsson G, Pedersen TR, Kjekshus J; 4S Group.

Lancet. 2004 Aug 28-Sep 3;364(9436):771-7.PMID: 15337403 [PubMed - indexed for MEDLINE]Related articles

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.

López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task Force on ACE-inhibitors of the European Society of Cardiology.

Eur Heart J. 2004 Aug;25(16):1454-70. Review. No abstract available. PMID: 15302105 [PubMed - indexed for MEDLINE]Related articlesFree article

Expert consensus document on beta-adrenergic receptor blockers.

López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task ForceOn Beta-Blockers of the European Society of Cardiology.

Eur Heart J. 2004 Aug;25(15):1341-62. Review. No abstract available. PMID: 15288162 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

Pyörälä K, Ballantyne CM, Gumbiner B, Lee MW, Shah A, Davies MJ, Mitchel YB, Pedersen TR, Kjekshus J; Scandinavian Simvastatin Survival Study (4S).

Diabetes Care. 2004 Jul;27(7):1735-40.PMID: 15220255 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.

Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK.

Clin Cardiol. 2004 Apr;27(4):199-203.PMID: 15119693 [PubMed - indexed for MEDLINE]Related articles